Difficulty: Medium
Average Score: 73%
Practice
Erythromycin should not be given to patient being treated with terfenadine because
Correct answer
B
Rationale
The correct answer is B) Dangerous ventricular arrhythmias can occur. When erythromycin is given with terfenadine, it can lead to QT interval prolongation, potentially causing ventricular arrhythmias like torsades de pointes. This is due to erythromycin inhibiting the metabolism of terfenadine, leading to increased levels of terfenadine in the body.
Option A is incorrect because erythromycin inhibits, not induces, the metabolism of terfenadine. Option C is incorrect because terfenadine does not inhibit the metabolism of erythromycin. Option D is incorrect because terfenadine's actions do not antagonize the antimicrobial action of erythromycin.
In an educational context, understanding drug interactions is crucial for healthcare professionals to prevent adverse effects and ensure patient safety. This scenario highlights the importance of knowing how certain drugs can interact to cause potentially life-threatening complications. Healthcare providers must be aware of these interactions to make informed decisions when prescribing medications to avoid harm to patients.
Option A is incorrect because erythromycin inhibits, not induces, the metabolism of terfenadine. Option C is incorrect because terfenadine does not inhibit the metabolism of erythromycin. Option D is incorrect because terfenadine's actions do not antagonize the antimicrobial action of erythromycin.
In an educational context, understanding drug interactions is crucial for healthcare professionals to prevent adverse effects and ensure patient safety. This scenario highlights the importance of knowing how certain drugs can interact to cause potentially life-threatening complications. Healthcare providers must be aware of these interactions to make informed decisions when prescribing medications to avoid harm to patients.